BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 37752992)

  • 1. EGFR trafficking: effect of dimerization, dynamics, and mutation.
    Schultz DF; Billadeau DD; Jois SD
    Front Oncol; 2023; 13():1258371. PubMed ID: 37752992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line.
    Nishimura Y; Yoshioka K; Bereczky B; Itoh K
    Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.
    Nishimura Y; Bereczky B; Ono M
    Histochem Cell Biol; 2007 May; 127(5):541-53. PubMed ID: 17361439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics reveals novel protein associations with early endosomes in an epidermal growth factor-dependent manner.
    Gosney JA; Wilkey DW; Merchant ML; Ceresa BP
    J Biol Chem; 2018 Apr; 293(16):5895-5908. PubMed ID: 29523688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation.
    Hoffman P; Carlin C
    Mol Cell Biol; 1994 Jun; 14(6):3695-706. PubMed ID: 8196613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of SNX1 in regulating EGFR endocytosis in a gefitinib-resistant NSCLC cell lines.
    Nishimura Y; Itoh K
    Cancer Drug Resist; 2019; 2(3):539-549. PubMed ID: 35582586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation.
    Tanaka T; Zhou Y; Ozawa T; Okizono R; Banba A; Yamamura T; Oga E; Muraguchi A; Sakurai H
    J Biol Chem; 2018 Feb; 293(7):2288-2301. PubMed ID: 29255092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
    Nishimura Y; Takiguchi S; Ito S; Itoh K
    Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-cell fluorescence imaging reveals high stoichiometry of Grb2 binding to the EGF receptor sustained during endocytosis.
    Fortian A; Sorkin A
    J Cell Sci; 2014 Jan; 127(Pt 2):432-44. PubMed ID: 24259669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome.
    Ceresa BP; Bahr SJ
    J Biol Chem; 2006 Jan; 281(2):1099-106. PubMed ID: 16282324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the tyrosine phosphorylated epidermal growth factor receptor with a 55-kD tyrosine phosphorylated protein at the cell surface and in endosomes.
    Wada I; Lai WH; Posner BI; Bergeron JJ
    J Cell Biol; 1992 Jan; 116(2):321-30. PubMed ID: 1370492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes.
    Pinilla-Macua I; Watkins SC; Sorkin A
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2122-7. PubMed ID: 26858456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress.
    Tong J; Taylor P; Moran MF
    Mol Cell Proteomics; 2014 Jul; 13(7):1644-58. PubMed ID: 24797263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.
    Burke P; Schooler K; Wiley HS
    Mol Biol Cell; 2001 Jun; 12(6):1897-910. PubMed ID: 11408594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors.
    Ménard L; Floc'h N; Martin MJ; Cross DAE
    Cancer Res; 2018 Jun; 78(12):3267-3279. PubMed ID: 29555874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trend in ligand-induced EGFR trafficking: A dual-mode clathrin-mediated endocytosis model.
    Zhou Y; Sakurai H
    J Proteomics; 2022 Mar; 255():104503. PubMed ID: 35093568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF.
    Oksvold MP; Skarpen E; Wierød L; Paulsen RE; Huitfeldt HS
    Eur J Cell Biol; 2001 Apr; 80(4):285-94. PubMed ID: 11370743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role of LIM kinase 1/cofilin pathway in regulating endocytic trafficking of EGF receptor in human breast cancer cells.
    Nishimura Y; Yoshioka K; Bernard O; Bereczky B; Itoh K
    Histochem Cell Biol; 2006 Nov; 126(5):627-38. PubMed ID: 16763828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve.
    Er EE; Mendoza MC; Mackey AM; Rameh LE; Blenis J
    Sci Signal; 2013 Jun; 6(279):ra45. PubMed ID: 23757022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where EGF receptors transmit their signals.
    Lill NL; Sever NI
    Sci Signal; 2012 Sep; 5(243):pe41. PubMed ID: 23012653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.